Compare · ALB vs CC
ALB vs CC
Side-by-side comparison of Albemarle Corporation (ALB) and Chemours Company (CC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALB and CC operate in Major Chemicals (Industrials), so they compete in similar markets.
- ALB is the larger of the two at $14.83B, about 5.4x CC ($2.72B).
- Over the past year, ALB is up 78.3% and CC is up 38.6% - ALB leads by 39.7 points.
- ALB has been more active in the news (11 items in the past 4 weeks vs 3 for CC).
- ALB has more recent analyst coverage (25 ratings vs 21 for CC).
- Company
- Albemarle Corporation
- Chemours Company
- Price
- $128.25+1.72%
- $18.69+3.12%
- Market cap
- $14.83B
- $2.72B
- 1M return
- -19.34%
- -13.15%
- 1Y return
- +78.35%
- +38.60%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NYSE
- IPO
- 2015
- News (4w)
- 11
- 3
- Recent ratings
- 25
- 21
Albemarle Corporation
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Chemours Company
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications. The Thermal & Specialized Solutions segment offers of refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment provides polymers and advanced materials. Its Chemical Solutions segment offers industrial chemicals used in gold production, industrial, and consumer applications. The company sells its products through direct channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Latest ALB
- Albemarle Corporation to Release Second Quarter 2026 Earnings Results on Wednesday, August 5, 2026
- Director Collins Michelle T was granted 1,252 shares, increasing direct ownership by 385% to 1,577 units (SEC Form 4)
- SEC Form 4 filed by Director Minor Glenda J
- Director Brlas Laurie was granted 1,286 shares, increasing direct ownership by 21% to 7,289 units (SEC Form 4)
- Director Cramer Ralf Hans covered exercise/tax liability with 942 shares and was granted 1,286 shares, increasing direct ownership by 6% to 5,723 units (SEC Form 4)
- Director Wolff Alejandro Daniel was granted 33 shares, increasing direct ownership by 0.25% to 13,044 units (SEC Form 4)
- SEC Form 4 filed by Director Widmar Mark R
- Director Steiner Gerald A was granted 1,286 shares, increasing direct ownership by 11% to 13,232 units (SEC Form 4)
- SEC Form 4 filed by Director Van Deursen Holly
- Director Oconnell Diarmuid B. was granted 1,286 shares, increasing direct ownership by 18% to 8,626 units (SEC Form 4)
Latest CC
- SEC Form 4 filed by Director Mather Courtney
- Chemours Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- Chemours Reaches Agreement with U.S. EPA to Resolve Claims Relating to PFAS
- SEC Form SD filed by Chemours Company
- Director Cranston Mary B was granted 7,182 shares, increasing direct ownership by 7% to 106,830 units (SEC Form 4)
- Director Turner Leslie M was granted 7,182 shares, increasing direct ownership by 41% to 24,603 units (SEC Form 4)
- Director Kane Erin N was granted 7,182 shares, increasing direct ownership by 11% to 74,063 units (SEC Form 4)
- Director Mather Courtney was granted 7,182 shares, increasing direct ownership by 50% to 21,643 units (SEC Form 4)
- Director Cowan Alister was granted 7,182 shares, increasing direct ownership by 20% to 43,881 units (SEC Form 4)
- Director Satterthwaite Livingston was granted 7,182 shares, increasing direct ownership by 30% to 30,808 units (SEC Form 4)